$214 Million is the total value of DAFNA Capital Management LLC's 75 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 48.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LOXO | Sell | LOXO ONCOLOGY INC | $27,527,000 | +31.4% | 158,675 | -12.6% | 12.89% | +26.5% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $15,027,000 | -0.8% | 96,000 | +2.1% | 7.04% | -4.5% |
| STXS | STEREOTAXIS INC | $10,534,000 | +15.8% | 13,680,554 | 0.0% | 4.93% | +11.5% | |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $8,901,000 | +23.6% | 131,770 | -0.8% | 4.17% | +18.9% |
| NXTM | NXSTAGE MEDICAL INC | $8,541,000 | +12.2% | 306,119 | 0.0% | 4.00% | +8.0% | |
| ATRC | Sell | ATRICURE INC | $8,530,000 | +6.8% | 315,345 | -19.0% | 3.99% | +2.8% |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $6,257,000 | +24.4% | 396,013 | 0.0% | 2.93% | +19.7% | |
| AKBA | AKEBIA THERAPEUTICS INC | $6,095,000 | +4.7% | 610,738 | 0.0% | 2.85% | +0.8% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $5,884,000 | -27.7% | 92,691 | +4.5% | 2.76% | -30.4% |
| DXCM | Sell | DEXCOM INC | $5,224,000 | -6.1% | 55,000 | -26.7% | 2.45% | -9.6% |
| LMNX | Sell | LUMINEX CORP | $5,017,000 | +4.7% | 169,891 | -25.3% | 2.35% | +0.7% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $4,906,000 | -5.3% | 73,745 | -6.9% | 2.30% | -8.9% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $4,471,000 | -1.1% | 45,508 | -16.5% | 2.09% | -4.8% |
| KURA | Buy | KURA ONCOLOGY INC | $4,359,000 | +83.1% | 239,500 | +88.6% | 2.04% | +76.3% |
| IMMU | Sell | IMMUNOMEDICS INC | $4,332,000 | +5.6% | 183,000 | -34.9% | 2.03% | +1.6% |
| ZGNX | Buy | ZOGENIX INC | $4,321,000 | +14.5% | 97,764 | +3.7% | 2.02% | +10.2% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $4,153,000 | -17.0% | 95,242 | -24.9% | 1.94% | -20.2% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $3,952,000 | -6.1% | 294,511 | -9.1% | 1.85% | -9.6% |
| GLPG | Buy | GALAPAGOS NVspon adr | $3,743,000 | -5.3% | 40,609 | +2.5% | 1.75% | -8.8% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,725,000 | -6.9% | 4,000,000 | 0.0% | 1.74% | -10.4% | ||
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $3,465,000 | -25.5% | 604,652 | -38.0% | 1.62% | -28.3% |
| IBB | ISHARES TR NASDAQ BIOTECHetf | $2,866,000 | +2.9% | 26,100 | 0.0% | 1.34% | -1.0% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $2,708,000 | +46.3% | 294,362 | -22.1% | 1.27% | +40.9% |
| ACHN | Buy | ACHILLION PHARMACEUTICALS | $2,682,000 | -16.7% | 947,636 | +9.1% | 1.26% | -19.8% |
| VBIV | Sell | VBI VACCINES INC | $2,570,000 | -26.4% | 934,691 | -6.3% | 1.20% | -29.2% |
| MNLO | New | MENLO THERAPEUTICS INC | $2,533,000 | – | 312,000 | +100.0% | 1.19% | – |
| New | INTEC PHARMA LTD JERUSALEM | $2,502,000 | – | 568,600 | +100.0% | 1.17% | – | |
| BEAT | Sell | BIOTELEMETRY INC | $2,453,000 | +13.7% | 54,500 | -21.6% | 1.15% | +9.4% |
| PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $2,375,000 | +11.8% | 2,500,000 | 0.0% | 1.11% | +7.5% | ||
| ARGX | Sell | ARGENX SEsponsored adr | $2,150,000 | -54.0% | 25,949 | -55.4% | 1.01% | -55.7% |
| SCYX | Sell | SCYNEXIS INC | $2,092,000 | -4.6% | 1,275,527 | -22.1% | 0.98% | -8.2% |
| CSII | New | CARDIOVASCULAR SYSTEMS INC | $1,915,000 | – | 59,200 | +100.0% | 0.90% | – |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $1,832,000 | +2.9% | 47,900 | +7.9% | 0.86% | -0.9% |
| ARDX | Buy | ARDELYX INC | $1,750,000 | +39.8% | 472,859 | +90.8% | 0.82% | +34.5% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $1,693,000 | -1.6% | 338,000 | +0.7% | 0.79% | -5.3% |
| ZFGN | New | ZAFGEN INC | $1,671,000 | – | 163,377 | +100.0% | 0.78% | – |
| INSULET CORPnote 1.375% | $1,664,000 | -2.7% | 1,500,000 | 0.0% | 0.78% | -6.4% | ||
| MGNX | Sell | MACROGENICS INC | $1,617,000 | -22.7% | 78,305 | -5.8% | 0.76% | -25.6% |
| AGTC | APPLIED GENETIC TECHNOL CORP | $1,558,000 | -3.9% | 421,000 | 0.0% | 0.73% | -7.6% | |
| IMDZ | IMMUNE DESIGN CORP | $1,495,000 | +37.9% | 328,500 | 0.0% | 0.70% | +32.8% | |
| INCY | Buy | INCYTE CORP | $1,441,000 | +15.3% | 21,500 | +43.3% | 0.68% | +11.0% |
| LPTX | Sell | LEAP THERPEUTICS INC | $1,365,000 | -17.8% | 151,643 | -24.2% | 0.64% | -20.9% |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $1,348,000 | – | 110,000 | +100.0% | 0.63% | – |
| NTUS | NATUS MEDICAL INC | $1,308,000 | +2.6% | 37,900 | 0.0% | 0.61% | -1.3% | |
| PRQR | Sell | PROQR THERAPEUTICS N V | $1,251,000 | +76.2% | 171,351 | -25.7% | 0.59% | +69.9% |
| CARA | Sell | CARA THERAPEUTICS INC | $1,203,000 | +3.6% | 62,811 | -33.0% | 0.56% | -0.4% |
| JNJ | JOHNSON AND JOHNSON | $1,141,000 | -5.3% | 9,400 | 0.0% | 0.53% | -8.9% | |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $1,106,000 | +1089.2% | 212,766 | +819.8% | 0.52% | +1051.1% |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $1,080,000 | +1.0% | 130,872 | -23.5% | 0.51% | -2.7% |
| ARQL | Sell | ARQULE INC | $1,043,000 | -25.3% | 188,664 | -61.1% | 0.49% | -28.2% |
| ADXS | ADVAXIS INC | $1,011,000 | -14.2% | 697,000 | 0.0% | 0.47% | -17.5% | |
| NVAX | New | NOVAVAX INC | $1,005,000 | – | 750,000 | +100.0% | 0.47% | – |
| OBSV | Buy | OBSEVA SA | $984,000 | +969.6% | 64,977 | +857.7% | 0.46% | +924.4% |
| BHVN | New | BIOHAVEN PHARMACEUTICALS HOLD | $929,000 | – | 23,500 | +100.0% | 0.44% | – |
| SNSS | SUNESIS PHARMACEUTICALS INC | $792,000 | -22.0% | 373,702 | 0.0% | 0.37% | -24.9% | |
| NTGN | New | NEON THERAPEUICS INC | $630,000 | – | 50,000 | +100.0% | 0.30% | – |
| BLUE | New | BLUEBIRD BIO INC | $628,000 | – | 4,000 | +100.0% | 0.29% | – |
| APTX | New | APTINYX INC | $604,000 | – | 25,000 | +100.0% | 0.28% | – |
| GLMD | New | GALMED PHARMACEUTICALS LTD | $595,000 | – | 50,000 | +100.0% | 0.28% | – |
| CYTK | New | CYTOKINETICS INC | $576,000 | – | 69,437 | +100.0% | 0.27% | – |
| URGN | Buy | UROGEN PHARMA LTD | $498,000 | +122.3% | 10,000 | +122.2% | 0.23% | +113.8% |
| MASI | MASIMO CORPORATION | $488,000 | +10.9% | 5,000 | 0.0% | 0.23% | +6.5% | |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $389,000 | -87.8% | 137,600 | -84.7% | 0.18% | -88.3% |
| BTX | BIOTIME INC | $374,000 | -23.5% | 181,600 | 0.0% | 0.18% | -26.5% | |
| BGNE | Sell | BEIGENE LTDsponsored adr | $307,000 | -75.1% | 2,000 | -72.7% | 0.14% | -76.0% |
| RDUS | New | RADIUS HEALTH INC | $295,000 | – | 10,000 | +100.0% | 0.14% | – |
| New | DEXCOM INCdbcv 0.750% 5/1 | $288,000 | – | 250,000 | +100.0% | 0.14% | – | |
| SLGL | SOL GEL TECHNOLOGIES LTD | $270,000 | -25.2% | 35,000 | 0.0% | 0.13% | -28.4% | |
| KDMN | New | KADMON HOLDINGS INC | $261,000 | – | 65,500 | +100.0% | 0.12% | – |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $261,000 | +15.0% | 250,000 | 0.0% | 0.12% | +10.9% | ||
| TBIO | New | TRANSLATE BIO INC | $253,000 | – | 20,000 | +100.0% | 0.12% | – |
| BLCM | New | BELLICUM PHARMACEUTICALS INC | $221,000 | – | 30,000 | +100.0% | 0.10% | – |
| DERM | Sell | DERMIRA INC | $212,000 | -65.1% | 23,000 | -69.7% | 0.10% | -66.4% |
| NEOS | NEOS THERAPEUTICS INC | $172,000 | -24.6% | 27,500 | 0.0% | 0.08% | -27.0% | |
| FTSV | New | FORTY SEVEN INC | $160,000 | – | 10,000 | +100.0% | 0.08% | – |
| BVXV | Exit | BIONDVAX PHARMACEUTICALS LTDspond ads | $0 | – | -3,399 | -100.0% | -0.01% | – |
| CLSD | Exit | CLEARSIDE BIOMEDICAL INC | $0 | – | -5,000 | -100.0% | -0.03% | – |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -7,900 | -100.0% | -0.04% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -7,500 | -100.0% | -0.06% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -79,969 | -100.0% | -0.08% | – |
| Exit | DEXCOM INCdbcv 0.750% 5/1 | $0 | – | -250,000 | -100.0% | -0.12% | – | |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -60,000 | -100.0% | -0.14% | – |
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -29,544 | -100.0% | -0.20% | – |
| Exit | INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $0 | – | -600,000 | -100.0% | -0.28% | – | |
| GEMP | Exit | GEMPHIRE THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.32% | – |
| Exit | IRONWOOD PHARMACEUTICALS INCdbcv 2.250% 6/1 | $0 | – | -573,000 | -100.0% | -0.33% | – | |
| SCPH | Exit | SCPHARMACEUTICALS INC | $0 | – | -55,844 | -100.0% | -0.34% | – |
| Exit | DERMIRA INCnote 3.000% 5/1 | $0 | – | -1,500,000 | -100.0% | -0.58% | – | |
| CGNT | Exit | COGENTIX MEDICAL INC | $0 | – | -310,382 | -100.0% | -0.58% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -267,100 | -100.0% | -0.62% | – |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -107,928 | -100.0% | -0.74% | – |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS IN | $0 | – | -105,000 | -100.0% | -0.77% | – |
| PODD | Exit | INSULET CORP | $0 | – | -32,484 | -100.0% | -1.37% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.